Trading Summary - November 28. No change at open to

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
244
Trading Summary - November 28.

No change at open to real ask, fake ask or bid.

Undercut ask attempts to paint down were bought out as usual by those increasing their year bottom price inventory for trading later - 900K total at .0004. Excess in buy order created a small .0004 bid.

The ask at .0005 - probably still including a fake amount within the NITE total (by which I mean the person who has put it up does not really want to sell at that level) - was at the level of 38M initially (down from a peak known fake amount of 55M) then an impatient person added another 3M..

The whale bid at .0003 remained in the 70M > 80M range all day. Some of those orders were renewed for a further 60 days on Nov 27.

Only 18M has been picked up on the bid at .0003 in 14 weeks - all of it from insignificant paint downs in conjunction with associated bashing comments on iHub from the usual suspects operating in a conspiracy by repeating nonsense to each other which they try to portray as fact.

The PR associated with the Q3 - that was filed on November 16 - has not been issued yet.

There is still a lot of activity going on at present for traders elsewhere.

Until the PR comes out highlighting the excellent results - and hopefully also updating future brand expansion plans - only those who were looking for the Q3 - who mostly already have their shares - have seen it.

Stay sharp if you don't already have all the shares you need to make your profit expectations in 2017 and up to Q4 in March 2018. Prior warning and / or scanner alerts of any significant buys when the PR comes out will not be given on iHub.

The long-term whales who trade $DIGX will continue to buy shares at any price that makes sense to them to use on multiple runs during the remainder of 2017 (there is usually a Q4 estimate + plans update in December) and throughout 2018. At least 2 of the main whales are prepared to bid for shares from the impatient at year end.

Content below the line mainly unchanged from last update - relevant to those that are new here.

As previously stated, the large additional share retirement of 275M shares since Jul 31 - on top of the 150M retired Dec 2016 > May 2017 making 425M total - has not been PR'ed yet either.

For 14 weeks now, nobody has been duped by the fake stacked ask at .0005 or the nonsense from the non-credible bashers on iHub to sell any significant amount for a loss at .0003.

Excellent update recently on the Verified Company Profile share structure at otcmarkets.com from the Transfer Agent (see new sticky #1902) - this has not been PR'ed yet to the wider investing community and has not been spotted by the inattentive on iHub:

O/S and A/S confirmed unchanged.

Float same as for all the runs this year - 50M reduction since Dec 2016.

Another 275M shares retired between Jul 31 and Oct 31 (as promised).

That takes total retired to 425M since May 31 - a significant reduction on such a small A/S and O/S for a stock in this price range.

There are at least 4 x whales who trade $DIGX continuously throughout each year who will be happy to take around 20M each if anyone is stupid or impatient enough to sell for a loss at any level below the current one. Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q3 and Q4. Shares bought at .0005 should easily return 100%+ at some point in 2017 or 2018.

In my experience, 70M>100M is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year will not require any shares bought above .0004 now so all others will be tradeable for up to 100% during the remaining runs in 2017.

As expected, the status quo has been maintained throughout the inter Q2/Q3 PR period with it making little difference to long-term traders whether shares are picked up at .0004/5/6 - they will see a profit on all of them by Q3 / Q4 and on various runs between. The big boys in DIGX will probably be aiming to have an inventory of 50M>150M for trading through to end-2017 and in 2018.

Also expect further elements of the .0003 bidders - particularly those unlikely to fill on paint downs in the time remaining before the next run prior to / at Q3 - to continue to buy .0004s and .0005s whilst they are still available until they meet their desired holding. Only 50% of the bid at .0003 hitting the ask at .0005 would be sufficient to take out even the current fake ask if left there.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan announced earlier - over the coming days, weeks and months..

The long whales will continue to buy at all prices that makes sense to them at any given point to have a cache for trading on any demand led run, the Q3 and through to the Annual Report in March 2018.

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>120M shares at these inter-Q bottom prices to trade over the next 6 months if there was even the remote possibility of a reverse split.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small).

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.




American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 1

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 3

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading

Top 5 Most Recently Viewed Articles

Kestra Medical Technologies Shows Remarkable Growth in Q3 Results

Updated Category News Views 147

Kestra Medical Technologies Highlights Growth in Fiscal Reports Kesda Medical Technologies, Ltd. (Nasdaq: KMTS), a pioneer in wearable medical devices and digital healthcare, has announced significant financial achievements in its recent third-quarter fiscal report. The company revealed its prowess in the marketplace, showing a remarkable 82% increase in revenues compared...

Continue Reading
Gentherm Earnings Drop: Can THRM Beat the EPS Blues?

Updated Category News Views 188

Gentherm (NASDAQ:THRM) is set to unveil its quarterly earnings this Thursday, February 19, 2026. With an expected earnings per share (EPS) of $0.56 on deck, traders are already buzzing about whether the company can pull off a surprise or if it’ll fall flat again. You gotta ask yourself—are these hopes just a mirage? Earnings Expectations: The Pressure Mounts The...

Continue Reading
Innovative Solutions in Fire Departments: A Revolutionary Shift

Updated Category News Views 153

A Vision Sparked by Experience Nate Gilbert started his career as a CPA before discovering his passion for software and emerging technologies. Through his journey, he recognized the potential of no-code development platforms to create sophisticated solutions swiftly and affordably. Inspired by this realization, he co-founded Fireproof Tech, driven to bring innovation into...

Continue Reading
Impact of KOLs and DOLs: Influencing HCPs through Social Media

Updated Category News Views 176

LiveWorld, Inc. (OTC Markets: LVWD) dropped a bombshell with findings from their collaboration with Sermo on the sway of Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs) in the healthcare space. The survey showed that KOLs are no longer just background players—they're calling shots that directly affect prescribing behaviors among Healthcare Providers...

Continue Reading
Update on Foresight Enterprise VCT's Voting Rights and Shares

Updated Category News Views 205

Understanding Total Voting Rights at Foresight Enterprise VCT PLC Foresight Enterprise VCT PLC LEI: 213800MWJNR3WZZ3ZP42 Foresight Enterprise VCT PLC has provided crucial information regarding its total voting rights, which shareholders must be aware of as they engage with the company. The latest announcement outlines the current state of the company's issued share...

Continue Reading